[
    {
        "title": "**Isolation of Treg and Teff cells**",
        "body": [
            {
                "title": "1.",
                "body": "Obtain fresh blood specimens from healthy donors and isolate PBMC by Lymphoprep density gradient medium."
            },
            {
                "title": "2.",
                "body": "Isolate total CD4<sup>+</sup> T cells using the CD4<sup>+</sup> T cell Isolation Kit as the following steps in brief. \r\n  \\(1) Resuspend total PBMC in 40 µl of MACS buffer per 10<sup>7</sup> cells, and incubate with 10 µl of Biotin-Antibody Cocktail per 10<sup>7</sup> cells for 10 min at 4°C. \r\n\n\n\\(2) Subsequently, add 30 µl of MACS buffer per 10<sup>7</sup> cells, and incubate cells with 20 µl of MicroBead Cocktail per 10<sup>7</sup> cells for 15 min at 4°C. \r\n\n\n\\(3) Wash cells with MACS buffer and resuspend cells in 1 ml of MACS buffer.\r\n\n\n\\(4) Prepare LS column by rinsing with 3 ml of MACS buffer. \r\n\n\n\\(5) Apply cell suspension onto the column and collect unlabeled cells that passed through."
            },
            {
                "title": "3.",
                "body": "Wash CD4<sup>+</sup> T cells \\(negative fraction) with MACS buffer."
            },
            {
                "title": "4.",
                "body": "Resuspend CD4<sup>+</sup> T cells with 100 µl of FACS buffer, and add 10 µl anti-CD4, anti-CD25, anti-CD127, respectively, mix and incubate for 15 min at 4°C."
            },
            {
                "title": "5.",
                "body": "Wash cells twice with 3 ml of FACS buffer, follow by FACS sorting for CD4<sup>+</sup>CD25<sup>hi</sup>CD127<sup>low/-</sup> as Treg cells and CD4<sup>+</sup>CD25<sup>-</sup> T cells as Teff cells. The purity of Treg cells and Teff cells ranged 95%-98%."
            }
        ]
    },
    {
        "title": "**Assay setup**",
        "body": [
            {
                "title": "6.",
                "body": "Treat Treg cells with TNF-α \\(50 ng/ml) or leave them in medium alone \\(control) in 96-well U-bottom plates \\(0.5-1.0×10<sup>5</sup> cells per well) in the presence of IL-2 \\(100 U/ml) for 24 hs."
            },
            {
                "title": "7.",
                "body": "Wash the resulting Treg cells twice with culture medium, and count the cells."
            },
            {
                "title": "8.",
                "body": "Label Teff cells with CFSE at 2 µM, 37°C for 8 min, then wash for three times with culture medium."
            },
            {
                "title": "9.",
                "body": "Inhibition assay in different conditions as follows. \r\n  \\(1) TNF-α pre-treatment assay: culture CFSE labeled Teff cells \\(1×10<sup>4</sup> cells per well) alone or with Treg cells \\(1×10<sup>4</sup> cells per well) that were either untreated or pretreated with TNF-α \\(50 ng/ml) in 96-well U-bottom plates. Maintain the culture in the presence of 2×10<sup>3</sup> anti-CD3/CD28 beads for 4 days.\r\n\n\n\\(2) TNF-α co-culture assay: culture CFSE labeled Teff cells \\(1×10<sup>4</sup> cells per well) alone or with Treg cells \\(1×10<sup>4</sup> cells per well) which were not pre-exposed to TNF-α, in the presence or absence of TNF-α \\(50 ng/ml) in 96-well U-bottom plates. Maintain the culture in the presence of 2×10<sup>3</sup> anti-CD3/CD28 beads for 4 days."
            },
            {
                "title": "10.",
                "body": "Measure proliferation of Teff cells by CFSE dilution in flow cytometry analyses. Express the results as percent inhibition: \\(1 − \\(experimental CFSE dilution/control CFSE dilution)) × 100%."
            }
        ]
    }
]